These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33127600)

  • 21. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
    Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
    Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19.
    Kow CS; Hasan SS
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):114-115. PubMed ID: 32933883
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden.
    Mattioli AV; Nasi M; Cocchi C; Farinetti A
    Future Cardiol; 2020 Nov; 16(6):539-542. PubMed ID: 32351128
    [No Abstract]   [Full Text] [Related]  

  • 24. The COVID-19 pandemic: lifestyle and cardiovascular risk factors.
    Bhatnagar D
    Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619
    [No Abstract]   [Full Text] [Related]  

  • 25. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.
    Pietrobon AJ; Teixeira FME; Sato MN
    Front Immunol; 2020; 11():579220. PubMed ID: 33193377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary embolism among critically ill patients with ARDS due to COVID-19.
    Soumagne T; Winiszewski H; Besch G; Mahr N; Senot T; Costa P; Grillet F; Behr J; Mouhat B; Mourey G; Fournel A; Meneveau N; Samain E; Capellier G; Piton G; Pili-Floury S
    Respir Med Res; 2020 Nov; 78():100789. PubMed ID: 33022510
    [No Abstract]   [Full Text] [Related]  

  • 27. Self-reported cutaneous manifestations in 1429 Brazilian COVID-19-infected patients.
    Miot HA; Ianhez M; Müller Ramos P
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e172-e173. PubMed ID: 33135246
    [No Abstract]   [Full Text] [Related]  

  • 28. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia.
    Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
    Metabolism; 2021 Jan; 114():154417. PubMed ID: 33157081
    [No Abstract]   [Full Text] [Related]  

  • 29. Dam if You Do, Dam if You Don't: Politics and Floods in the Shadow of COVID-19 in Sudan.
    Modber MAKA; Ahmadi A; Mogessie YG; Ibrahim YMES; Adebisi YA; Lucero-Prisno DE
    Health Secur; 2021; 19(2):232-234. PubMed ID: 33756083
    [No Abstract]   [Full Text] [Related]  

  • 30. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for skin cancer consultation and surgery during COVID-19 pandemic.
    Brochez L; Baurain JF; Del Marmol V; Nikkels A; Kruse V; Sales F; Stas M; Van Laethem A; Garmyn M
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1876-1878. PubMed ID: 32789960
    [No Abstract]   [Full Text] [Related]  

  • 32. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
    Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
    Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.
    Langerbeins P; Fürstenau M; Gruell H; Klein F; Persigehl T; Rybniker J; Seeger-Nukpezah T; Kochanek M; Hallek M; Eichhorst B; Koehler P; Böll B
    Eur J Haematol; 2020 Oct; 105(4):508-511. PubMed ID: 32575156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 pandemic and some observations about management of breast cancer at private practice.
    Altundag K
    J BUON; 2020; 25(5):2530. PubMed ID: 33277884
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection?
    Hodžić A; de la Fuente J; Cabezas-Cruz A
    ACS Infect Dis; 2020 Dec; 6(12):3104-3108. PubMed ID: 33180463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrapulmonary SARS-CoV-2 manifestations.
    Carvalho T
    Nat Med; 2020 Dec; 26(12):1806. PubMed ID: 33288941
    [No Abstract]   [Full Text] [Related]  

  • 38. [COVID-19, tuberculosis and induced mortality].
    Underner M; Perriot J; Peiffer G; Jaafari N
    Rev Mal Respir; 2020 Dec; 37(10):836-838. PubMed ID: 33069503
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.
    Shen C; Li Q; Wei Y; Li Y; Li J; Tao J
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33303577
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.